Literature DB >> 28389161

A case of extensive pharyngeal vascular malformation successfully treated with Kampo medicine.

Keiko Ogawa-Ochiai1, Keigo Osuga2, Kuniaki Hidaka3, Kengo Nakahata4, Yuko Tazuke4, Yoshifumi Yamamoto5, Shuichiro Uehara4, Hiroomi Okuyama4.   

Abstract

OBJECTIVE: To present the efficacy of Japanese-traditional medicine (Kampo) for a case with vascular malformation.
METHODS: A case study and literature review. PATIENT: A 62-year-old female presented with dysphagia and spitting blood. Esophagogastroduodenoscopy showed a longitudinal lobulated and septated mass in the posterior pharynx. On MR imaging, the mass showed hyperintensity on T2-weighted images and heterogeneous enhancement on Gadlinium-enhanced T1-weighted images, suggestive of a low-flow vascular malformation. INTERVENTION: According to the Kampo diagnosis, kamisyouyousan and ninjinyoueito were prescribed to this patient. The effect of Kampo medicine was evaluated with improvement of her symptoms and volumetry of MRI findings. RESULT: The longitudinal pharyngeal mass was markedly decreased and her symptoms disappeared after 2 years of Kampo administration.
CONCLUSIONS: Kampo medicine can be a novel alternative therapy for VM.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Kampo medicine; Vascular malformation; kamishoyosan; ninjinyoeito

Mesh:

Substances:

Year:  2017        PMID: 28389161     DOI: 10.1016/j.anl.2017.03.008

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  2 in total

1.  Good Rehabilitation Outcomes and Improved Nutritional Status After Treatment With the Japanese Herbal Medicine Ninjin'yoeito in an Elderly Patient With Hip Fracture and Sarcopenia: A Case Report.

Authors:  Akinori Morinaga; Hiroki Nakamura; Kenji Hattanmaru; Natasya Trivena Rokot; Yoko Kimura; Takashi Ito
Journal:  Front Nutr       Date:  2020-06-26

Review 2.  Perspectives on the Use of Ninjin'yoeito in Modern Medicine: A Review of Randomized Controlled Trials.

Authors:  Shin Takayama; Ryutaro Arita; Minoru Ohsawa; Akiko Kikuchi; Hiromichi Yasui; Toshiaki Makino; Yoshiharu Motoo; Tadashi Ishii
Journal:  Evid Based Complement Alternat Med       Date:  2019-09-02       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.